Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bitopertin in acute exacerbation of schizophrenia
NCT01234779Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of bitopertin in schizophrenia, sponsored by Roche. Started Feb 2011; status: completed.
02
Drugs
bitopertin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01234779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01234779.